Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
25174-4 Amikacin 8.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25174-4 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Amikacin 8 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 8 ug/mL; AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25175-1 Amikacin 16.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25175-1 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Amikacin 16 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 16 ug/mL; AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25176-9 Amikacin 32.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25176-9 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Amikacin 32 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 32 ug/mL; AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25177-7 Amikacin 12.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25177-7 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Amikacin 12 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 12 ug/mL; AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25178-5 Amikacin 30.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25178-5 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Amikacin 30 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 30 ug/mL; AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25179-3 Amikacin 6.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25179-3 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Amikacin 6 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6 ug/mL; AFB; Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
2518-9 Lactate SCnc BldA Pt Qn &nbsp; &nbsp; ACTIVE Lactate [Moles/volume] in Arterial blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 2518-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lactate BldA-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
25180-1 Ciprofloxacin 2.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25180-1 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ciprofloxacin 2 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25181-9 Ciprofloxacin 4.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25181-9 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ciprofloxacin 4 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25182-7 Kanamycin 5.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25182-7 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Kanamycin 5 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 5 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kantrex; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25183-5 Ethionamide 11.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25183-5 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ethionamide 11 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Trecator; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25184-3 rifAMPin 14.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE rifAMPin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25184-3 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 rifAMPin 14 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 14 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25185-0 Streptomycin 6.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25185-0 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Streptomycin 6 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6 ug/mL; AFB; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c232; C295; Cidam est; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Novostrep; Point in time; Random; SlowMyco; Solustrep; Streptocol; Strepto-fatol; Streptomyc; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25186-8 Pyrazinamide 25.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25186-8 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 PZA 25 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 25 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; PZA; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25187-6 Ethambutol 7.5 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25187-6 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ethambutol 7.5 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myambutol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutol; Olbutam; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25188-4 Ciprofloxacin 8.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25188-4 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ciprofloxacin 8 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 8 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25189-2 Ciprofloxacin 5.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25189-2 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ciprofloxacin 5 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 5 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.26 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
2519-7 Lactate SCnc BldV Pt Qn &nbsp; &nbsp; ACTIVE Lactate [Moles/volume] in Venous blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 2519-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lactate BldV-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Venous 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
25190-0 Clarithromycin 8.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25190-0 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clarithro 8 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 8 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biaxin; Claripen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klacid; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25191-8 Clarithromycin 16.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25191-8 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clarithro 16 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 16 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biaxin; Claripen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klacid; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25192-6 Clarithromycin 32.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25192-6 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Clarithro 32 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 32 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biaxin; Claripen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klacid; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25194-2 Ethambutol 5.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25194-2 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ethambutol 5 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 5 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myambutol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutol; Olbutam; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25195-9 Ethambutol 10.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25195-9 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ethambutol 10 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 10 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; ID; Inagen; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myambutol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutol; Olbutam; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25196-7 Ethionamide 5.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25196-7 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ethionamide 5 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 5 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Trecator; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
25198-3 Ethionamide 15.0 ug/mL Susc Isolate Pt OrdQn Method for Slow-growing mycobacteria &nbsp; ACTIVE Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 25198-3 &nbsp; Method for Slow-growing mycobacteria &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Ethionamide 15 ug/mL Islt SlowMyco &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 15 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Trecator; Tuberculosis 2.73 2 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
104,672 results found